On the recordMarch 29, 2023
A source of pride of this subcommittee is our history of bipartisan work to advance user fee agreements.
Source
congress.govEditor's note · Context
Eshoo highlights the committee's bipartisan efforts in drug development.
Share & report
More from Anna Eshoo
Mar 27, 2023
Well, it seems to me that some of us speak out on what we consider censorship.
Jan 31, 2023
The country has had three waves of opioid deaths: prescription opioids, heroin opioids, and now fentanyl.
Other voices in this conversation
